Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development

Journal of Bone and Mineral Research

Volumn 13, Issue 4, 1998, Pages 673-682

  Dodds, R A ^a   Connor, J R ^a   Drake, F ^a   Feild, J ^a   Gowen, Maxine ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; EMBRYO; EMBRYO DEVELOPMENT; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

ACID PHOSPHATASE; ANIMALS; BONE DEVELOPMENT; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CARBOXYLESTERASE; CARBOXYLIC ESTER HYDROLASES; CARTILAGE; CATHEPSINS; CELL DIFFERENTIATION; COLORING AGENTS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GESTATIONAL AGE; IN SITU HYBRIDIZATION; ISOENZYMES; MICE; MICE, INBRED BALB C; OSTEOCLASTS; PREGNANCY; RNA, MESSENGER;

EID: 0031979693     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.4.673     Document Type: Article

References (35)

1. Tezuka K-I, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, Hakeda Y, Kumegawa M 1994 Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 269:1106-1109.
2. Inaoka T, Bilbe G, Ishibashi O, Tezuka K-I Kamegawa M, Kokubo T 1995 Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206:89-96.
3. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Bartlow R, Hastings G, Gowen M 1996 Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516.
4. Bromme D, Okamoto K 1995 Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary: Molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe-Seyler 376:379-384.
5. Shi G-P, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ 1995 Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 357:129-134.
6. Li YP, Alexander M, Wucherpfennig AL, Yelick P, Chen W, Stashenko P 1995 Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Miner Res 10:1197-1202.
7. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA 1996 Proteolytic activity of human osteoclast cathepsin K: Expression, purification, activation, and substrate identification. J Biol Chem 271:12517-12524.
8. Delaisse J-M, Eeckhout Y, Vaes G 1980 Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem J 192:365-368.
9. Delaisse J-M, Eeckhout Y, Vaes G 1984 In vitro and in vivo evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun 125:441-447.
10. Delaisse J-M, Boyde A, Maconnachie E, Ali NN, Sear CHJ, Eeckhout Y, Vaes G, Jones SJ 1987 The effects of inhibitors of cysteine proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305-313.
11. Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC 1994 Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 56:118-130.
12. Lerner UH, Grubb A 1992 Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J Bone Miner Res 7:433-439.
13. Everts V, Delaisse J-M, Korper W, Niehof A, Vaes G, Beertsen W 1992 Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 150: 221-231.
14. Votta BJ, Levy MA, Badger A, Dodds RA, James IE, Thompson S Bossard MJ, Carr T, Connor JR, Tomaszek TA, Szewczuk L, Drake FH, Veber DF, Gowen M 1997 Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res, 12:1396-1406.
15. Gelb BD, Shi GP, Chapman HA, Desnick RJ 1996 Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
16. Johnson MR, Polymeropoulos MH, Vos HL, Ortiz de Luna RI, Francomano CA 1996 A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res 6:1050-1055.
17. Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37:25-31.
18. Mundy GR, Roodman GD 1987 Osteoclast ontogeny and function. In: Peck W (ed.) Bone and Mineral Research. Elsevier Science Publishers, New York, NY, pp. 209-279.
19. Chambers TJ 1989 The origin of the osteoclast. In: Peck W (ed.) Bone and Mineral Research. Elsevier Science Publishers, New York, NY, U.S.A., pp. 1-25.
20. Takahashi N, Udagawa N, Tanaka S, Murakami H, Owan I, Tamura T, Suda T 1994 Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol 163:212-221.
21. Baron R, Neff L, Tran Van P, Nefussi J-R, Vigner A 1986 Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 122:363-378.
22. Marks SC 1983 The origin of the osteoclast. J Oral Pathol 12:226-256.
23. Gothlin G, Ericsson JLE 1976 The osteoclast: review of ultrastructure, origin and structure-function relationship. Clin Orthop Rel Res 120:201-231.
24. Scheven BA, Kawilarang De Haas EW, Wassenaar AM, Nijweide PJ 1986 Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and vitro. Anat Rec 214:418-423.
25. Andersson G, Ek-Rylander B, Minkin C 1991 Acid phosphatases. In: Rifkin B, Gay CV (eds.) The Biology and Physiology of the Osteoclast. CRC Press, Boca Raton, FL, U.S.A., pp. 55-80.
26. Connor JR, Dodds RA, James IE, Gowen M 1995 Human osteoclast and giant cell differentiation: The apparent switch from NSE to TRAP activity coincides with the in situ expression of osteopontin mRNA. J Histochem Cytochem 43:1193-1201.
27. Dodds RA, Gowen M 1994 The growing osteophyte: A model system for the study of human bone development and remodeling in situ. J Histotech 17:37-45.
28. Chayen J, Bitensky L 1991 Practical Histochemistry, 2nd Ed. John Wiley & Sons, London, U.K.
29. Zeller R, Rogers M 1991 In situ hybridization to cellular RNA. In: Janssen K (ed.) Current Protocols in Molecular Biology. John Wiley & Sons, New York, NY, pp. 14.2.1-14.3.11.
30. Sommer B, Bickel M, Hofstetter W, Wetterwald A 1996 Expression of matrix proteins during the development of mineralized tissues. Bone 9:371-380.
31. Caplan AI, Pechak DG 1987 The cellular and molecular embryology of bone formation. In: Peck WA (ed.) Bone and Mineral Research. Elsevier Science Publishers, New York, NY, U.S.A., pp. 117-183.
32. Malone JD, Teitelbaum S, Griffin GL, Senior RM, Kahn AJ 1982 Recruitment of osteoclasts precursors by purified bone matrix consituents. J Cell Biol 92:227-230.
33. Blavier L, Delaisse JM 1995 Matrix metalloproteases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 108: 3649-3659.
34. Rantakokko J, Aro HT, Savontaus M, Vuorio E 1996 Mouse cathepsin K: cDNA cloning and prominant expression of the gene in osteoclasts, and in some hypertrophing chondrocytes during mouse development. FEBS Letts 393:307-313.
35. Dodds RA, Connor JR, Drake F, Feild J, Gowen M 1996 Cathepsin K mRNA expression is restricted to osteoclasts during fetal and neonatal mouse development. J Bone Miner Res 11:S180.